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Abstract
Background: Paclitaxel (PTX), a chemotherapeutic agent, and monosodium glutamate
(MSG) have oxidative effects on testicular tissue.
Objective: In this study, the effects of MSG administration on the exacerbation of
testicular tissue alterations related to PTX treatment were evaluated.
Materials and Methods: MSG (30 & 60 mg/kg i.p.) was administrated to six groups
(n = 8/each) of adult mice before or after PTX treatment: control, PTX-treated, MSG30
+ PTX, MSG60 + PTX, PTX + MSG30, and PTX + MSG60. Following the euthanizing,
the body weight measurement, pituitary–testicular axis hormonal analysis and serum
lipid peroxidation index assessment was prepared, testicular histomorphometry
(tubular diameter and germinal epithelium height), immunohistochemistry of p53
was completed. Microscopic indices of spermatogenesis (tubular differentiation,
spermiogenesis and repopulation indices) were studied.
Results: Body weight was not changed significantly. The levels of testosterone (p =
0.0001), follicle stimulating hormone (p = 0.019), and luteinizing hormone (p = 0.08) were
decreased while the level of lipid peroxidation index was increased (p = 0.208) in the
treated groups. The histomorphometry indices (p < 0.0001 and p = 0.001, respectively),
germ cells population (p<0.05) andmicroscopic indices of spermatogenesis (p = 0.001,
p = 0.005, p<0.0001, respectively) were significantly reduced in all treated groups. The
administration of MSG before PTX treatment induces more changes. The most positive
reaction to p53was observed in MSG30 or 60 + PTX groups compared to other groups.
Conclusion: The administration of MSG could intensify testicular tissue alterations
related to PTX chemotherapy.
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1. Introduction
Paclitaxel (PTX) is a mitotic inhibitor which
is used as a chemotherapeutic agent for the
treatment of solid tumors such as ovarian and
prostatic cancers (1). The administration of PTX
induced the alteration of spermatogenesis in rats
(2). Monosodium glutamate (MSG) as a sodium
salt of glutamic acid (amino acid) has toxic effects
on various tissues of mammals (3, 4). Accord-
ingly, it has been reported that some alterations
of testicular tissue function such as hemorrhage
and abnormal sperm production or morphology
could be related to MSG consumption (4, 5).
Moreover, environmental risk factors could affect
the spermatogenesis process through induction of
alterations in structure and function of germ cells
(6). Due to the susceptibility of germinal epithelium
of male reproductive system to chemotherapy
agents and the lack of purposeful studies about
the effects of the administration of MSG before
or after chemotherapy, on the structural and func-
tional alterations of testicular tissue induced by
chemotherapy, this study was designed. Accord-
ingly, given the importance of the nutrition and diet
treatment in chemotherapy patients, the aim of this
study was to evaluate the dose-dependent effects
of the administration of MSG on the PTX-related
testicular tissue alterations.
2. Materials and Methods
PTX (2 mg/kg b.w., Paclitaxel Stragen, STRA-
GEN PHARMA SA, Switzerland) was administered
to mice intraperitoneally once per day for five
consecutive days (1). MSG (30 & 60 mg/kg b.w.,
Sigma-Aldrich, St Louis, MO 63178, USA) was
administrated intraperitoneally (7).
2.1. Animal procedures
Forty eight adult male Syrian mice with mean
body weight 30.43 ± 3.59 gr were divided
randomly into six groups (n = 8/each) and placed in
standard cages under 12-hr light/dark cycle. During
the period of the experiment, the standard labora-
tory chow and water were available ad libitum to
the animals.
2.2. Experimental design
The animals were divided into six groups (Figure
1). 1) Control (normal and healthy mice that did
not receive any type of treatment; 2) Paclitaxel
treated (PTX) mice that received PTX for five
consecutive days and after they were received
normal saline for 28 days; 3) PTX+MSG30 group
that received low-dose MSG daily for 28 days
one week after the administration of PTX; 4)
PTX+MSG60 group in which a high dose of MSG
was administrated one week following the adminis-
tration of PTX; 5) MSG30+PTX group that consisted
of MSG30-treated animals that received MSG for
28 days before the administration of PTX; and 6)
MSG60+PTX group that were treated similar to the
previous group but with a high dose of MSG. The
normal saline was injected to the animals of the
control and PTX groups in an equivalent volume of
PTX and MSG.
2.3. Blood hormonal measurement
and lipid peroxidation (MDA) assay
At the end of the study, the animals were euth-
anized and the blood plasma was separated and
kept at –80°C for the measurement of hormonal
and malondialdehyde (MDA) levels. The standard
ELISA method with commercial assay kits was pre-
pared for quantitative analysis of FSH (Pishtazteb
diagnostics, Iran), LH (Pishtazteb diagnostics, Iran),
and testosterone levels (Monobind Inc. USA). The
detection of MDA was carried out by commercial
lipid peroxidation (MDA) assay kit based on MDA–
TBA (thiobarbituric acid) complex formation.
2.4. Tissue preparation and
histological techniques
Testicular tissues were fixed in 10% buffered
formaldehyde solution (pH = 7.4). The paraffin
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embedded samples were cut and stained by
Hematoxylin and Eosin for histomorphometrical
observations.
2.5. Histomorphometric analysis
The height of germinal epithelium (GEH) and
diameter of seminiferous tubules (STD) was inves-
tigated for morphometric analysis. Tissue micro-
graphs were obtained by AmScope digital camera
(AmScope MD 500) and processed by the image
analysis software (AmScope 3.7). The samples
were studied under ×100 magnifications.
2.6. Evaluation of spermatogenesis in
testicular tissue
The assessment of spermatogenesis in testicular
tissue was completed by the quantification of the
number of seminiferous tubules with more than
three layers of germinal cells derived from type-A
spermatogonia (tubular differentiation index: TDI);
the ratio of active spermatogonia to inactive cells
(repopulation index: RI) and the ratio of seminif-
erous tubules with spermatozoids to the empty
tubules (spermiogenesis index: SPI) (8).
2.7. Immunohistochemistry (IHC) of
p53
Paraffin-embedded tissue sections were pre-
pared for IHC. Antigen retrieval was carried out on
deparaffinised and rehydrated slides kept in 10 mM
sodium citrate solution (pH 6.0) with temperature
95°C in a water bath for 40 min. Briefly, the activity
of endogenous peroxidase was blocked with 0.3%
H2O2. Tissue slides were washed with PBS (pH 7.2)
and incubated with primary antibody (1:500) (Saint
Johnes laboratory) at 4°C overnight. Sections were
treated with horseradish peroxidase (HRP) conju-
gated secondary antibody in a humidified chamber
for 1 hr. Diaminobenzidine (DAB) chromogen was
added to tissue sections and incubated for 5 min.
Tissue slides were dehydrated and cover slipped
after hematoxylin counterstaining.
Figure 1. Flowchart of animal grouping and time schedule of the administration of MSG and PTX during the experimental study.
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2.8. Ethical consideration
All animal procedures used in this study
were observed and approved by the Veterinary
Research Ethics of the University of Tabriz
standards for the care and use of laboratory
animals (Code number: FVM.REC.1396.940).
2.9. Statistical analysis
All results are expressed as mean ± SD. Statisti-
cal significance of differences between experimen-
tal groups was performed by one-way ANOVA fol-
lowed by Tukey’s multiple comparison test (Graph-
Pad PRISM® software version 5.04, Inc. USA).




Table I shows the initial and final body weight
in experimental groups. Accordingly, there was no
significant difference between the experimental
groups for initial and final body weight (p > 0.05).
The lowest final body weight was observed in the
MSG60 + PTX group. Similarly, the lowest body
weight gain was observed in the MSG60 + PTX
and MSG30 + PTX groups. The administration of
MSG before the treatment of animals with PTX led
to lower weight gain in comparison to the other
groups.
3.2. Hormonal assay and serum MDA
Table II shows the changes in the hormones of
the pituitary–testicular axis and serum MDA levels.
Accordingly, the administration of PTX and MSG
led to a decrease in the blood levels of FSH,
LH, and testosterone. The blood concentration
of testosterone was reduced significantly in all
the treated groups in comparison to the control
group (p = 0.0001). The most reduction in FSH
level was observed in the MSG30 + PTX and
MSG60 + PTX groups (p = 0.019), while the blood
concentration of LH was significantly decreased
only in the MSG60 + PTX group (p = 0.083).
The mean of blood MDA levels was increased
in all the treated groups in comparison to the
control group (p > 0.208). In this regard, the
administration of MSG with PTX induced more
elevation of blood MDA levels compared to the
untreated PTX group. Moreover, the administration
of MSG before an injection of PTX led to more
increment of MDA levels in comparison to the other
groups that received MSG after the injection of
PTX.
3.3. Testicular histomorphometry and
the population of germinal epithelium
The use of PTX led to decrease of tubular diame-
ter and the GEH in comparison to the control group
(Figure 2). Simultaneous administration of PTX and
MSG led to decrease of morphometric indices. The
mean of tubular diameter was reduced in all exper-
imental groups compared to the control group
(p < 0.0001). Moreover, the GEH was decreased
in the experimental groups. This decrease was
significant in (PTX + MSG60), (MSG30 + PTX), and
(MSG60 + PTX) groups (p = 0.0013). Accordingly,
these decrements were dose-dependent andmore
visible in the MSG + PTX groups in comparison to
the PTX +MSG groups. Themean of the population
of spermatogonia, spermatocytes, and spermatids
was reduced significantly in all the treated groups
in comparison to the control group (p < 0.0001, p
= 0.0004, p < 0.0001, respectively). The population
of Sertoli cells was reduced in all the treated groups
in comparison to the control animals (p = 0.105).
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3.4. Microscopic indices of
spermatogenesis
The mean of microscopic indices of spermato-
genesis (TDI, SPI, and RI) were reduced in all
the treated groups compared to the control group
(Table III). The administration of PTX led to a
significant decrease of these indices in comparison
to the control group (p < 0.05). Accordingly, the
lowest degree of these indices was recorded in the
MSG60 + PTX group.
3.5. Histology of testicular tissue
Figure 3 shows the histology of testicular tissue
in the experimental groups. Accordingly, in the
PTX-treated group, cellular and structural alter-
ations such as tubular atrophy, interstitial edema,
and depletion in cell population were observed
(Figure 3B). These changes were detected in
groups treated with PTX and MSG simultaneously
(Figure 3 CF). These structural changes were
observed more in the MSG + PTX groups (Figures
3E and 3F) in comparison to the PTX + MSG groups
(Figures 3C and 3D).
3.6. Immunohistochemistry of p53
The study of testicular seminiferous tubules for
the detection of the expression of p53 showed a
different reactivity (Figure 4). Immunohistochemical
study of testicular tissue of the control group
revealed faint immunostaining in the control group
(Figure 4A). The positive reaction areas were
increased in the treated groups in comparison to
the control group. In this regard, the expression
of p53 was observed in the germinal epithelium
of the seminiferous tubules. Moreover, the positive
reaction areas were observed in more degrees
in the MSG30 + PTX and MSG60 + PTX groups
(Figures 4E and 4F) compared to the PTX + MSG30
and PTX + MSG60 groups (Figure 4C and 4D).
Also, the administration of MSG led to an increase
of p53 expression in the MSG-treated animals
in comparison to the PTX-treated group. High
dose of MSG induces more positive reaction areas
compared to a low dose of MSG.
Table I. Mean of initial and final body weight in experimental groups
Initial body weight (gr) Final body weight (gr) Weight gain (gr)
Control 27.80 ± 6.78 36.00 ± 3.65 8.2
PTX 31.60 ± 1.67 36.00 ± 2.00 4.4
PTX + MSG30 28.40 ± 2.96 34.40 ± 2.88 6.0
PTX + MSG60 31.20 ± 2.68 35.60 ± 2.96 4.4
MSG30 + PTX 32.80 ± 1.09 35.00 ± 3.28 2.2
MSG60 + PTX 30.80 ± 1.78 34.00 ± 1.41 3.2
P-value 0.198 0.816
Data are presented as Mean ± SD.
PTX: Paclitaxel; MSG: Monosodium glutamate
Table II. Blood hormonal and malondialdehyde levels in experimental groups
FSH (IU/L) LH (IU/L) Testosterone (ng/ml) Serum MDA nmol/mg
protein
Control 0.28 ± 0.02 0.24 ± 0.02 1.07 ± 0.13 0.78 ± 0.13
PTX 0.25 ± 0.04 0.19 ± 0.05 0.84 ± 0.13𝛼 0.95 ± 0.22
PTX + MSG30 0.25 ± 0.03 0.20 ± 0.03 0.76 ± 0.11𝛼 0.97 ± 0.19
PTX + MSG60 0.23 ± 0.04 0.21 ± 0.04 0.83 ± 0.12𝛼 0.94 ± 0.26
MSG30 + PTX 0.22 ± 0.04𝛼 0.20 ± 0.03 0.82 ± 0.14𝛼 1.00 ± 0.20
MSG60 + PTX 0.22 ± 0.03𝛼 0.18 ± 0.02𝛼 0.79 ± 0.04𝛼 1.15 ± 0.23
P-value 0.019 0.083 0.0001 > 0.208
Data are presented as Mean ± SD. 𝛼 Significant different in comparison to the control group.
PTX: Paclitaxel; MSG: Monosodium glutamate; FSH: Follicle stimulating hormone; LH: Luteinizing hormone; MDA:
Malondialdehyde
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Table III. Mean of microscopic indices of spermatogenesis in experimental groups
TDI (%) SPI (%) RI (%)
Control 69.70 ± 12.26 67.70 ± 10.03 84.14 ± 9.26
PTX 50.90 ± 15.26𝛼 49.10 ± 9.63𝛼 63.00 ± 10.49𝛼
PTX + MSG30 54.10 ± 11.72 53.60 ± 10.32 55.86 ± 8.29𝛼
PTX + MSG60 48.0 ± 11.10𝛼 51.60 ± 12.83𝛼 58.14 ± 8.03𝛼
MSG30 + PTX 52.50 ± 12.20𝛼 54.30 ± 13.99 56.14 ± 11.44𝛼
MSG60 + PTX 45.50 ± 12.99𝛼 46.40 ± 14.91𝛼 51.86 ± 5.78𝛼
P-value 0.001 0.005 < 0.0001
Data are presented as Mean ± SD. 𝛼 Significant different in comparison to control group.
PTX: Paclitaxel; MSG: Monosodium glutamate; TDI: Tubular differentiation index; SPI: Spermiogenesis index; RI: Repopulation
index
Figure 2. Testicular tissue histomorphometry and the population of germinal epithelium in experimental groups. (𝛼Significantly
different in comparison to the control group. Data are presented as mean ± SD.)
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Figure 3. Histology of testicular tissue in experimental groups. (A) Control group. Seminiferous tubules with normal architecture;
(B) PTX-treated group. Tubular atrophy with a decrease of the cellular population and nuclear displacement of Sertoli cells (red
arrow). Decrease in the population of spermatocytes (black arrow) is visible; (C) PTX + MSG60 group. Tubular atrophy with a
decrease in the population of spermatocytes (black arrow). Some tubules were observed without spermatogenic cell line (red
arrow); (D) PTX + MSG30 group. Decrease of cellular population (red asterisks) with interstitial edema; (E) MSG30 + PTX group.
Increase in connective tissue (black asterisks), tubular atrophy (black arrow) with a decline in the cell population (red asterisks)
is visible; (F) MSG60 + PTX group. Tubular atrophy with severe depletion in the cell population was observed. (AST: Affected
seminiferous tubule; ST: seminiferous tubule. H & E staining; Magnification: ×400.)
Figure 4. Expression of p53 protein in testicular tissue. Immunohistochemical study. (A) Faint positive reaction observed (Arrows)
in seminiferous tubules (ST); (B) positive reaction to p53 expression (Arrows) in PTX-treated group; (C&D) p53 positive reaction in
germinal epithelium (Arrows) in the PTX + MSG30 and PTX + MSG60 groups; (E&F) Increment of positive reaction was observed in
germinal epithelium (Arrows) with positive reactivity of interstitial connective tissue (Arrowheads) in the MSG30 + PTX and MSG60
+ PTX groups. Magnification ×200.
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4. Discussion
In this study, the effect of MSG on testicular
tissue of paclitaxel-treated mice was evaluated.
The results obtained from this study showed that
the administration of MSG during the period of
chemotherapy (paclitaxel) can exacerbate the tes-
ticular tissue alterations related to PTX treatment.
The comparison of the results obtained from the
measurement of various cellular and histological
parameters revealed that there is a difference in
observed changes between formerly administra-
tion of MSG and consequent administration of
MSG. Additionally, one of the prominent findings
in this study was that the administration of MSG
before treatment of animals with PTX could induce
more changes in the structure and function of
testicular tissue compared to other groups which
received the MSG subsequent of PTX treatment.
Various environmental factors could induce differ-
ent fertility alterations in male reproductive system
(9). The toxicity of MSG on the structure and func-
tion of testicular tissue of human and experimental
animals has been reported (10, 11). In this regard, it
has been stated that the structural alteration of tes-
ticular tissue related to the administration of MSG
is mediated by oxidative damage (12). Furthermore,
some studies demonstrated certain abnormalities
as male infertility, obesity and hypogonadism asso-
ciated to MSG consumption (13, 14). Some tissues
and organs of rats as well as testicular tissue have
the glutamate receptors (15, 16). Oxidative stress
is involved in decline of completion of functional
maturation and capacitation of spermatozoa due to
decrement of glutathione levels in male germ cells
(17, 18).
One of the possible mechanisms of testicular
tissue alterations in MSG-treated animals could be
related to oxidative damages of the germ cells
following the administration of MSG. The present
study showed that the blood MDA contents were
enhanced in all experimental groups compared
to the control animals. This increase of serum
MDA levels were observed in the groups treated
with both PTX and MSG in comparison to the
PTX-treated mice. Accordingly, our results showed
that the administration of MSG prior to the PTX
treatment induces more elevation in blood levels
of MDA in dose-dependent manner. Along with the
aforementioned results, the most histomorphome-
trical and histochemical alterations were observed
in the MSG + PTX groups compared to the PTX
+ MSG groups. These results confirm that the
administration of MSG through the induction of
oxidative stress could involve in the intensity of
cellular and tissue alterations related to the PTX
treatment. In this regard, it has been reported that
the PTX has a direct effect on the formation of free
radicals by inducing intracellular oxidative stress
(19-21). However, in our study the tissue MDA levels
were not measured.
In this study, the negative impact of PTX and
MSG on the reproductive system of male mice was
considered by noteworthy histological changes
such as decline of spermatogenesis indices,
decrease in tubular morphometry, disarrangement,
and depletion of germinal epithelium. In MSG-
treated animals, the reduction of the conversion of
spermatogonia to primary spermatocytes leads to
diminished TDI and SPI rate. Aswell, the increase of
the population of inactive spermatogonia reduces
RI index which induces a decline in the population
of primary spermatocytes and the reduction in
the production of spermatozoids consequently.
Accordingly, the results of this study showed that
the administration of MSG before or following of
PTX treatment induce a reduction of RI in dose-
dependent manner. In some studies, it has been
stated that the RI decreases in the PTX-treated
rats (22). This reduction of RI could be related to
the antiproliferative properties of PTX. However,
the results of our study revealed that the animals
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which received MSG prior to PTX had a lower RI
percentage in comparison to the other animals that
received MSG after the PTX treatment. According
to these results, we can suggest that the adminis-
tration of MSG could be effective in exacerbation of
tissue damages induced by PTX through cytotoxic
processes such as excessive ROS production and
induction of oxidative stress.
The results of the present study showed that the
treatment with PTX reduces weight gain process.
The weight loss has not been reported in the
PTX-administrated adult rats (23). Conversely, an
increase of body weight has been reported in the
administration of MSG (24). Our previous study
revealed that the administration of MSG at high
dose induces more weight gain in comparison to
its lower dose (9). It seems, the effects of MSG
on the weight gain process can occur in a dose-
dependent manner. Once 40 days of study, the
rate of weight gain in the animals treated with
PTX was lower in comparison to the control group.
These changes of body weight could be related
to PTX-induced anorexia and subsequently low
food intake. Decrease in weight gain that occurs
in all PTX-treated animals could be related to the
PTX central effects or pathologic conditions of
gastrointestinal system that lead to a decrease of
the activities of digestive system. In this regard,
peripheral neuropathy is the most common side
effects of PTX administration (25). However, it
does not seem that the PTX-induced neuropa-
thy could be the main factor in the process of
lower weight gain. So, according to the previous
studies (22), it appears that the interruption of
the motility of digestive system associated to
decreased neuronal activities of gastrointestinal
system related to PTX treatment could be effective
in lower weight gain in the PTX-treated animals.
These changes in weight gain were more visible
when MSG was administrated before the PTX
treatment.
It has been reported that the administration of
MSG induces a reduction of serum LH and testos-
terone levels (26). Accordingly, the administration
of MSG to adult mice induces cellular damage
of hypothalamic neurons in arcuate and preoptic
nucleuses (11, 27, 28). As a result, the dysfunction
of the hypothalamic–pituitary–gonadal axis could
induce some alterations in the testicular function
(29). In this study, the administration of PTX had
no significant effect on the pituitary gonadotropins
but the blood levels of testosterone reduced signif-
icantly. This reduction of testosterone levels could
be related to the negative effects of PTX on the
Leydig cells’ division which may lead to a decline
in the population of these cells as a main source
of testosterone production. This factor could be
one of the mechanisms involved in the reduction
of male fertility following the chemotherapy.
PTX is a mitotic inhibitor chemotherapeutic
agent used for the treatment of solid tumors such
as ovarian and prostatic cancers (25). The binding
of PTX to β-tubulin of microtubules leads to an
increase in microtubule polymerization (30). It has
been demonstrated that the administration of PTX
influences actively dividing and post-meiotic cells
which induce some alterations in spermatogen-
esis by damaging spermatogonia in the delayed
periods (31). In this study, the results obtained
from testicular morphometry and cell population
revealed an alteration in the structure of semi-
niferous tubules. In this regard, the depletion of
tubular cell population, especially decrease in the
number of dividing cells, induces decrement in
spermatogenic indices which accomplished with
structural changes in seminiferous tubules. These
changes were observed in the PTX and other
groups that received MSG before or after the PTX
treatment. Accordingly, it seems that the treatment
with PTX following the administration of MSG
induces these aforementioned changes in more
degrees.
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In this study, for the estimation of DNA damage
in germinal cell lineage, the expression of p53
protein was evaluated. According to our results,
the most positive reactions were observed in
the testicular tissue of animals that had received
MSG prior to the PTX treatment. These results
indicate that the administration of MSG before the
PTX treatment could induce more DNA damage
and subsequently cell death. Programmed cell
death (apoptosis) is a normal regulatory process
in testicular tissue and occurs in various phases
in germinal epithelium (32, 33). The changes in
nuclear DNA of testicular germ cell lineage could
involve in spermatogenesis failure (34). Further-
more, cellular stress such as severe DNA damage
induced by exogenous factors could generate the
upregulation of p53 expression that can activate
the initiation of apoptosis or repair pathways in
the cell (35). Likewise, the over expression of p53
proteins could induce the abnormal cell death and
consequently decrease in the cell population and
subsequently the reduction in sperms quality and
quantity (32, 33, 36). According to the increase
of p53 positive areas in testicular samples of PTX
+ MSG or MSG + PTX groups, we can propose
that the administration of MSG to PTX treated ani-
mals could accelerate the PTX-associated germinal
epithelium apoptosis through upregulation of p53,
dose-dependently.
5. Conclusion
According to the results of this study, it has
been concluded that the administration of MSG
at the time of PTX chemotherapy could involve in
intensifying of structural and functional changes of
testicular tissue which may lead to several degrees
of fertility alterations. Since the mechanism of the
activity of PTX differs from the MSG, it appears that
the raise of tissue oxidative stress related to MSG
administration could induce DNA damage which
leads to a decline in the population of germ cells.
Finally, the reduction in the cell division induced
by PTX with negative tissue-damaging effects of
MSG and the alteration of the pituitary–testicular
axis hormones could promote further damage of
testicular tissue. It seems that the administration
of MSG prior to PTX treatment has more negative
effects on reproductive system in comparison to
the administration of MSG after the paclitaxel
treatment.
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